Showing results (141-150 of 172) with videos related to
Sort By:
Pageof 18
Trials|September 17, 2020
Can low-dose methotrexate reduce effusion-synovitis and symptoms in patients with mid- to late-stage knee osteoarthritis? Study protocol for a randomised, double-blind, and placebo-controlled trialZhaohua Zhu, Qinghong Yu, Xiaomei Leng, et al.The Lancet. Rheumatology|January 23, 2024
Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trialXiaomei Leng, Piotr Leszczyński, Sławomir Jeka, et al.BMJ Open|March 21, 2025
Evaluating the performance of large language models in health education for patients with ankylosing spondylitis/spondyloarthritis: a cross-sectional, single-blind study in ChinaYong Ren, Yue-Ning Kang, Shuang-Yan Cao, et al.Rheumatology (Oxford, England)|March 29, 2011
The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in ChinaManlong Xu, Zhiming Lin, Xinghe Deng, et al.Arthritis Research & Therapy|November 8, 2024
Outgrowth of Escherichia is susceptible to aggravation of systemic lupus erythematosusLian Gui, Xiaoyu Zuo, Junmei Feng, et al.Biomed Research International|August 15, 2015
Predictive Factors of Clinical Response of Infliximab Therapy in Active Nonradiographic Axial Spondyloarthritis PatientsZhiming Lin, Zetao Liao, Jianlin Huang, et al.Clinical Rheumatology|November 28, 2017
Prevalence of psychological disorders, sleep disturbance and stressful life events and their relationships with disease parameters in Chinese patients with ankylosing spondylitisYutong Jiang, Mingcan Yang, Qing Lv, et al.Frontiers in Immunology|January 28, 2021
Age-Specific Imbalance of Circulating Tfh Cell Subsets and Its Association With Gout-Targeted Kidney ImpairmentYefei Huang, Xinyu Wu, Lian Gui, et al.International Journal of Rheumatic Diseases|March 1, 2019
2018 APLAR axial spondyloarthritis treatment recommendationsLai Shan Tam, James Cheng-Chung Wei, Amita Aggarwal, et al.The Journal of Rheumatology|October 11, 2002
Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profilesJieruo Gu, Markus Rihl, Elisabeth Märker-Hermann, et al.Pageof 18